Medicus Pharma Ltd (MDCX)

$2.41 +0.16 (7.11%)
Market Cap 42.94M
Revenue (ttm) 0.00
Net Income (ttm) -11.16M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 266,000
Avg Vol 443,652
Day's Range N/A - N/A
Shares Out 17.82M
Stochastic %K 94%
Beta N/A
Analysts Strong Sell
Price Target $16.15

Company Profile

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company was founded in 2015 and is headquartered in Toronto, Canada.

Industry: Drug Manufacturers - General
Sector: Healthcare
Address:
One First Canadian Place, 100 King Street West Suite 3400, Toronto, Canada
Condemor
Condemor Sep. 13 at 7:17 AM
$MDCX 2.50 is my limit to start covering. Not to worry as monday will move back to 2.20
0 · Reply
Ugo1945
Ugo1945 Sep. 12 at 10:21 PM
$MDCX THIS STOCK WILL change the skin cancer game. Nowadays you see a spot especially the elderly and the dermatologist tells them they need to do mohs surgery to test spot and they cut out half your flesh , an 80 year year old with a spot doesn’t have to worry about frozen pathology, basil cell cancerous spot are the slowest moving cancers and can take up to 20 years for it to spread. Mdcx will change the game
1 · Reply
Condemor
Condemor Sep. 12 at 7:41 PM
$MDCX hi guys, i am in real trouble if this keeps going up and will need to cover soon with so much lost
1 · Reply
Ugo1945
Ugo1945 Sep. 12 at 7:35 PM
$MDCX this company is Amazing and will provide alternative options for those who chose not to have mohs surgery that as we know has been dermatologists money makers. I just feel dermatologists are to quick to recommend mohs surgery , and patients being vulnerable have no choice.
0 · Reply
bullrider19
bullrider19 Sep. 12 at 7:17 PM
$MDCX slow and steady lets GO!!!!!!!!! $7+soon
0 · Reply
Condemor
Condemor Sep. 12 at 7:05 PM
$MDCX fkn hell…
0 · Reply
Condemor
Condemor Sep. 12 at 4:36 PM
$MDCX until it doesnt break 2.30 it wont go up. And it is never going to happen
0 · Reply
Condemor
Condemor Sep. 12 at 3:03 PM
$MDCX sorry longs, cannot go above 2.26. Sell all!!!
0 · Reply
Condemor
Condemor Sep. 12 at 2:56 PM
$MDCX todays close will be 2.190. Monday 1.90 lets goooooooo
0 · Reply
Condemor
Condemor Sep. 12 at 2:52 PM
$MDCX lets go boys and girlies, shoooort it
0 · Reply
Latest News on MDCX
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Sep 8, 2025, 7:30 AM EDT - 6 days ago

Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Medicus Pharma Ltd. Completes Acquisition of Antev Limited

Sep 2, 2025, 7:30 AM EDT - 12 days ago

Medicus Pharma Ltd. Completes Acquisition of Antev Limited

Medicus Pharma Ltd. Provides Update on Doxorubicin Containing Novel Microneedle Array (D-MNA) Clinical Development Program for the Treatment of Basal Cell Carcinoma (BCC) of the Skin and Reports Second Quarter 2025 Financial Highlights

Aug 21, 2025, 7:30 AM EDT - 24 days ago

Medicus Pharma Ltd. Provides Update on Doxorubicin Containing Novel Microneedle Array (D-MNA) Clinical Development Program for the Treatment of Basal Cell Carcinoma (BCC) of the Skin and Reports Second Quarter 2025 Financial Highlights

Medicus Pharma Ltd. Announces a Memorandum of Understanding (MOU) with Helix Nanotechnologies Inc. to Develop Thermostable Infectious Disease Vaccines

Aug 4, 2025, 7:30 AM EDT - 5 weeks ago

Medicus Pharma Ltd. Announces a Memorandum of Understanding (MOU) with Helix Nanotechnologies Inc. to Develop Thermostable Infectious Disease Vaccines

Medicus Pharma Ltd. Announces Voting Results Following the Annual and Special Meeting of Shareholders

Jul 23, 2025, 7:30 AM EDT - 7 weeks ago

Medicus Pharma Ltd. Announces Voting Results Following the Annual and Special Meeting of Shareholders

Medicus Pharma Ltd. to Present at BTIG Virtual Biotech Conference 2025

Jul 21, 2025, 7:30 AM EDT - 7 weeks ago

Medicus Pharma Ltd. to Present at BTIG Virtual Biotech Conference 2025

Medicus Pharma Ltd. Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA)

Jul 8, 2025, 7:30 AM EDT - 2 months ago

Medicus Pharma Ltd. Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA)

Medicus Pharma: High-Risk But Higher Reward For Their Potential Breakthrough Skin Cancer Treatment

Jul 4, 2025, 9:49 AM EDT - 2 months ago

Medicus Pharma: High-Risk But Higher Reward For Their Potential Breakthrough Skin Cancer Treatment

Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK

Jun 30, 2025, 7:30 AM EDT - 2 months ago

Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK

Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer

Jun 23, 2025, 7:30 AM EDT - 2 months ago

Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer

Medicus Pharma Ltd. to Present at 2025 Bio International Convention

Jun 12, 2025, 7:30 AM EDT - 3 months ago

Medicus Pharma Ltd. to Present at 2025 Bio International Convention

Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses

Jun 9, 2025, 7:30 AM EDT - 3 months ago

Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses

Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering

Jun 2, 2025, 1:40 PM EDT - 3 months ago

Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering

Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering

May 29, 2025, 8:30 PM EDT - 3 months ago

Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering

Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

May 22, 2025, 7:30 AM EDT - 4 months ago

Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfolio

May 12, 2025, 2:20 PM EDT - 4 months ago

Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfolio

Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd.

Apr 28, 2025, 7:30 AM EDT - 4 months ago

Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd.

Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)

Apr 21, 2025, 7:30 AM EDT - 5 months ago

Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)

Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering

Mar 10, 2025, 4:05 PM EDT - 6 months ago

Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering

Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering

Mar 6, 2025, 8:30 PM EST - 6 months ago

Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering

Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Mar 6, 2025, 7:30 AM EST - 6 months ago

Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to United Arab Emirates (UAE) Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Feb 27, 2025, 7:30 AM EST - 7 months ago

Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to United Arab Emirates (UAE) Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)

Feb 11, 2025, 7:41 AM EST - 7 months ago

Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)

Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch

Dec 12, 2024, 7:30 AM EST - 9 months ago

Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch

Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region

Dec 2, 2024, 7:30 AM EST - 10 months ago

Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region

Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

Nov 18, 2024, 7:30 AM EST - 10 months ago

Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States

Nov 15, 2024, 4:47 PM EST - 10 months ago

Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States

Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States

Nov 13, 2024, 6:45 PM EST - 10 months ago

Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States

Condemor
Condemor Sep. 13 at 7:17 AM
$MDCX 2.50 is my limit to start covering. Not to worry as monday will move back to 2.20
0 · Reply
Ugo1945
Ugo1945 Sep. 12 at 10:21 PM
$MDCX THIS STOCK WILL change the skin cancer game. Nowadays you see a spot especially the elderly and the dermatologist tells them they need to do mohs surgery to test spot and they cut out half your flesh , an 80 year year old with a spot doesn’t have to worry about frozen pathology, basil cell cancerous spot are the slowest moving cancers and can take up to 20 years for it to spread. Mdcx will change the game
1 · Reply
Condemor
Condemor Sep. 12 at 7:41 PM
$MDCX hi guys, i am in real trouble if this keeps going up and will need to cover soon with so much lost
1 · Reply
Ugo1945
Ugo1945 Sep. 12 at 7:35 PM
$MDCX this company is Amazing and will provide alternative options for those who chose not to have mohs surgery that as we know has been dermatologists money makers. I just feel dermatologists are to quick to recommend mohs surgery , and patients being vulnerable have no choice.
0 · Reply
bullrider19
bullrider19 Sep. 12 at 7:17 PM
$MDCX slow and steady lets GO!!!!!!!!! $7+soon
0 · Reply
Condemor
Condemor Sep. 12 at 7:05 PM
$MDCX fkn hell…
0 · Reply
Condemor
Condemor Sep. 12 at 4:36 PM
$MDCX until it doesnt break 2.30 it wont go up. And it is never going to happen
0 · Reply
Condemor
Condemor Sep. 12 at 3:03 PM
$MDCX sorry longs, cannot go above 2.26. Sell all!!!
0 · Reply
Condemor
Condemor Sep. 12 at 2:56 PM
$MDCX todays close will be 2.190. Monday 1.90 lets goooooooo
0 · Reply
Condemor
Condemor Sep. 12 at 2:52 PM
$MDCX lets go boys and girlies, shoooort it
0 · Reply
Condemor
Condemor Sep. 12 at 2:40 PM
$MDCX hellou arseis! How are yah doin’
2 · Reply
Condemor
Condemor Sep. 12 at 2:38 PM
$MDCX told ya guys, this is going down!!!!!
0 · Reply
bullrider19
bullrider19 Sep. 12 at 1:41 PM
$MDCX $7+
0 · Reply
Condemor
Condemor Sep. 12 at 1:32 PM
$MDCX told you, this wont go much up
0 · Reply
Condemor
Condemor Sep. 12 at 1:26 PM
$MDCX guys, dont expect this one goes green today
0 · Reply
bullrider19
bullrider19 Sep. 12 at 11:41 AM
$MDCX time to ride the BULL
0 · Reply
bullrider19
bullrider19 Sep. 11 at 9:30 PM
$MDCX BUY BUY going to $7+ soon
0 · Reply
Condemor
Condemor Sep. 11 at 8:02 PM
$MDCX ok guys, a positive day can happen, but tomorrow will fall at 2.00. Short and strong on my 270k short at 2.07
1 · Reply
remicoleman
remicoleman Sep. 11 at 7:50 PM
$MDCX NXXT momentum waking up throttle wide open ⚡️
0 · Reply
Condemor
Condemor Sep. 11 at 7:15 PM
$MDCX will go to 2.10 quickly, i am not worried
0 · Reply
remicoleman
remicoleman Sep. 11 at 5:54 PM
$MDCX NXXT watch liquidity bursts pre market and into open smart money likely accumulating ahead of catalysts bids step up consistently
0 · Reply
2TrustHim
2TrustHim Sep. 11 at 5:43 PM
$MDCX Here Comes $2.75 and Over $6.00 For $GALT $CLWT Got Growth Coming!!! WATCH!!!
0 · Reply